ERBB2 and breast carcinoma: Lie et al. reported that the gene body enhancer of human epidermal growth factor receptor-2 (HER2) and hypomethylation of HER2 gene body enhancer region in breast cancers contribute to HER2 expression by increasing its accessibility to transcription factors [88].